{"id":"W2560782884","doi":"10.1182/blood.v124.21.4551.4551","title":"Comparative Efficacy Among 3rd Line Post-Imatinib Chronic Phase-Chronic Myeloid Leukemia (CP-CML) Patients after Failure of Dasatinib or Nilotinib Tyrosine Kinase Inhibitors","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Nilotinib; Dasatinib; Medicine; Imatinib; Ponatinib; Internal medicine; Bosutinib; Imatinib mesylate; Tyrosine-kinase inhibitor; Tyrosine kinase; Oncology; Myeloid leukemia; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01106135,0.0008921361,0.008039027,0.00584312,0.0002768375,0.002372405,0.001026502,0.001503036,0.003185146],"category_scores_gemma":[0.02506631,0.0004775265,0.0116859,0.004600427,0.0007502871,0.001541158,0.0008709373,0.00094218,0.0001833496],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0023777,"about_ca_system_score_gemma":0.002875396,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001890906,"about_ca_topic_score_gemma":0.005418578,"domain_scores_codex":[0.9886333,0.004609328,0.004424752,0.0008564368,0.001264005,0.0002122447],"domain_scores_gemma":[0.9737943,0.01646948,0.007158753,0.0003573846,0.001878817,0.0003412712],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"observational","study_design_scores_codex":[0.01224061,0.0001383373,0.004381275,0.8149223,0.1241355,0.0001671418,0.0002469562,0.0002695003,0.0006815936,0.000347168,0.0004610477,0.04200856],"study_design_scores_gemma":[0.0106742,0.01070252,0.0348581,0.2771495,0.6487994,0.000700885,0.0007004928,0.0003507055,0.001205084,0.00106667,0.01366409,0.0001283468],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.01957985,0.9771088,0.0001758157,0.0002100408,0.000132564,0.001296066,0.000795189,0.000007299883,0.0006943776],"genre_scores_gemma":[0.3808924,0.6118144,0.00174398,0.0009197397,0.0002655367,0.002721586,0.001119967,0.00001172061,0.0005107558],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.01106135,"threshold_uncertainty_score":0.05849868,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.014707307269293,"score_gpt":0.2779437002241801,"score_spread":0.2632363929548871,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}